muraglitazar
CV168-048
Phase 3 small_molecule completed
Quick answer
muraglitazar for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed